Ficha del valor · trimestre archivado
HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
17Tenedores rastreados
-1Δ titulares
23.07MAcciones mantenidas
$729.13MValor declarado
+1Nuevas posiciones
−2Cierres
Señales de momentum (gestores comparables):
amplitud de titulares -5.6% ·
flujo de acciones -0.8% ·
nuevas posiciones netas -5.9%
— fórmula
Distribución amplia — caída de acciones y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +5 | 37.66M | $1.37B | +12 | −6 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | — |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | — |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | — | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | — |
| Q2 2024 | 13 | — | 3.50M | $105.70M | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasivo) | 6.74M | — | $212.89M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 5.11M | — | $161.50M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasivo) | 5.11M | — | $161.50M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasivo) | 5.11M | — | $161.50M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasivo) | 5.11M | — | $161.50M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasivo) | 5.11M | — | $161.50M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 4.69M | — | $148.15M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Fidelity (FMR) ✦ | 4.69M | — | $148.15M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 4.69M | — | $148.15M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (pasivo) | 1.63M | +3.2% | $51.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | Marshall Wace ✦ | 1.21M | +36.3% | $38.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Marshall Wace ✦ | 1.21M | +36.3% | $38.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Geode Capital Management ✦ (pasivo) | 1.05M | +9.2% | $33.32M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (pasivo) | 1.05M | +9.2% | $33.32M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Renaissance Technologies ✦ | 929.47K | +10.6% | $29.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Arrowstreet Capital ✦ | 906.91K | +127.6% | $28.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 252.98K | -20.9% | $7.99M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 252.98K | -20.9% | $7.99M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Two Sigma Investments ✦ | 238.89K | -30.9% | $7.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 152.03K | -8.6% | $4.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 152.03K | -8.6% | $4.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 152.03K | -8.6% | $4.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 152.03K | -8.6% | $4.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 152.03K | -8.6% | $4.80M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Gotham Asset Management ✦ | 39.71K | +71.4% | $1.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | T. Rowe Price ✦ | 34.83K | +16.7% | $1.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 41 | Point72 Asset Management ✦ | 33.78K | Nuevo | $1.07M | 0.0% | New | 1 | SEC ↗ |
| 42 | Millennium Management ✦ | 29.29K | -62.7% | $925,532 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | Wellington Management ✦ | 15.73K | -3.8% | $497,131 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 44 | Wellington Management ✦ | 15.73K | -3.8% | $497,131 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 45 | Wellington Management ✦ | 15.73K | -3.8% | $497,131 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 46 | Wellington Management ✦ | 15.73K | -3.8% | $497,131 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 47 | Norges Bank ✦ (pasivo) | 11.12K | -79.4% | $351,487 | 0.0% | ▼ Trim | 5 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Point72 Asset Management | $1.07M | 0.0% |
Posición cerrada
| Citadel Advisors | $28.62M | era 0.0% |
| Adage Capital Partners | $5.58M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 306 tenedores, 54.70M acciones, $1.38B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API